Biology Reference
In-Depth Information
Awab, G.R., Pukrittayakamee, S., Imwong, M., Dondorp, A.M., Woodrow, C.J., et al., 2010.
Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghani-
stan: an open randomized, non-inferiority, trial. Malar. J. 9, 105.
Bacon, D.J., Jambou, R., Fandeur, T., Le Bras, J., Wongsrichanalai, C., et al., 2007. World
Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility.
J. Infect. Dis. 6, 120.
Baird, J.K., Hoffman, S.L., 2004. Primaquine therapy for malaria. Clin. Infect. Dis. 39,
1336-1345.
Baird, J.K., Surjadjaja, C., 2011. Consideration of ethics in primaquine therapy against
malaria transmission. Trends Parasitol. 27, 11-16.
Baird, J.K., Decker-Jackson, J.E., Davidson, D.E.J., 1984. An in vitro micro-volume proce-
dure for rapid measurement of erythrocytic hexose monophosphate shunt activity. Int.
J. Biochem. 16, 1049-1052.
Baird, J.K., Davidson, D.E.J., Decker-Jackson, J.E., 1986a. Oxidative activity of hydroxyl-
ated primaquine analogs. Non-toxicity to glucose-6-phosphate dehydrogenase-deficient
human red blood cells in vitro. Biochem. Pharmacol. 35, 1091-1098.
Baird, J.K., McCormick, G.J., Canfield, C.J., 1986b. Effects of nine synthetic putative metab-
olites of primaquine on activity of the hexose monophosphate shunt in intact human
red blood cells in vitro. Biochem. Pharmacol. 35, 1099-1106.
Baird, J.K., Basri, H., Bangs, M.J., Subianto, B., Patchen, L.C., et al., 1991. Resistance to chlo-
roquine by
Plasmodium vivax
in Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 44, 547-552.
Baird, J.K., Basri, H., Subianto, B., Fryauff, D.J., McElroy, P.D., et al., 1995a. Treatment of
chloroquine resistance
Plasmodium vivax
with chloroquine and primaquine or halofan-
trine. J. Infect. Dis. 171, 1678-1682.
Baird, J.K., Fryauff, D.J., Basri, H., Bangs, M.J., Subianto, B., et al., 1995b. Primaquine for
prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia.
Am. J. Trop. Med. Hyg. 52, 479-484.
Baird, J.K., Leksana, B., Masbar, S., Fryauff, D.J., Sutanihardja, M.A., et al., 1997. Diagnosis
of resistance to chloroquine by
Plasmodium vivax
: timing of recurrence and whole blood
chloroquine levels. Am. J. Trop. Med. Hyg. 56, 621-626.
Baird, J.K., Lacy, M.D., Basri, H., Barcus, M.J., Maguire, J.D., et al., 2001. Randomized, paral-
lel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia.
Clin. Infect. Dis. 33, 1990-1997.
Baird, J.K., Fryauff, D.J., Hoffman, S.L., 2003. Primaquine for prevention of malaria in travel-
ers. Clin. Infect. Dis. 37, 1659-1667.
Baird, J.K., 1984. Methylene blue-mediated hexose monophosphate shunt stimulation in
human red blood cells in vitro: independence from intracellular oxidative injury. Int.
J. Biochem. 16, 1053-1058.
Baird, J.K., 2004. Chloroquine resistance in
Plasmodium vivax
. Antimicrob. Agents Che-
mother. 48, 4075-4083.
Baird, J.K., 2007. Neglect of
Plasmodium vivax
malaria. Trends Parasitol. 23, 533-539.
Baird, J.K., 2008. Real-world therapies and the problem of vivax malaria. N. Engl. J. Med.
359, 2601-2603.
Baird, J.K., 2009. Resistance to therapies for infection by
Plasmodium vivax
. Clin. Microbiol.
Rev. 22, 508-534.
Baird, J.K., 2010. Eliminating malaria - all of them. Lancet 376, 1883-1885.
Baird, J.K., 2011. Resistance to chloroquine unhinges vivax malaria therapeutics. Antimicrob.
Agents Chemother. 55, 1827-1830.
Baird, J.K., 2012a. Elimination therapies for the endemic malarias. Curr. Infect. Dis.
Rep.10.1007/s11908-012-0250-z.
Baird, J.K., 2012b. Tropical health sustainability. In: Meyers, R.A. (Ed.), Encyclopedia of
Sustainability Science and Technology, Springer Verlag, New York, pp. 11134-11163.
